Search results
Psoriasis: Features That May Affect Biologic Rx Outcomes
Medscape· 3 days agoSeveral clinical characteristics were negatively associated with responses to biologics in a...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 7 hours agoThis approval is a significant milestone, making Skyrizi now available for four different conditions in the U.S., including psoriatic arthritis, plaque psoriasis& ...
Beese Fulmer Investment Management Inc. Sells 137 Shares of Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 12 hours agoBeese Fulmer Investment Management Inc. reduced its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.6% during the first quarter, according to the company in its most recent 13F filing with ...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 1 day agoThe studies also achieved a key secondary endpoint of endoscopic improvement. Skyrizi is already...
In a 'gold rush' for treating bowel disease, AbbVie clears one more stage
Crain s Chicago Business· 1 day agoWith the arrival of biosimilar competition for its blockbuster drug Humira, AbbVie has said much of its sales growth potential lies with these two anti-inflammatories. In April, the North Chicago ...
FDA Approves Skyrizi for Ulcerative Colitis
Medscape· 2 days agoThe approval is the fourth indication for the anti–interleukin 23 monoclonal antibody after approval for Crohn's disease, psoriatic arthritis, and plaque...
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 1 day agoEverything you need to know about the art and science of drug naming in five minutes or less,...
AbbVie (NYSE:ABBV) Shares Up 0%
ETF DAILY NEWS· 5 days agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 0% during mid-day trading on Thursday . The company traded as high as $166.45 and last traded at $166.15. ABBV has been the topic ...
Biogen Inc. (NASDAQ:BIIB) Receives $286.50 Consensus Target Price from Analysts
ETF DAILY NEWS· 6 days agoShares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-six brokerages that are covering the firm, MarketBeat Ratings ...
Optimist Retirement Group LLC Purchases New Shares in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 7 days agoOptimist Retirement Group LLC acquired a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange ...
